The Plasbumin-5 market is witnessing steady growth over the forecast period, supported by increasing demand for advanced plasma-derived therapies, rising focus on patient blood management.
Read More
The Plasbumin-25 market is witnessing steady growth over the forecast period, supported by rising liver disease incidence, increasing icu admissions.
Read More
The Plasbumin-20 market is witnessing steady growth over the forecast period, supported by rising geriatric population, increase in critical care admissions.
Read More
The Phesgo market is witnessing steady growth over the forecast period, supported by expansion of home-based oncology treatment models, rising investments in combination biologic therapies.
Read More
The Pertzye market is witnessing steady growth over the forecast period, supported by expansion of personalized digestive care, rising adoption of advanced enzyme formulations.
Read More
The Perjeta (Pertuzumab) market is witnessing steady growth over the forecast period, supported by growth of her2 positive patient identification, expansion into adjuvant therapy settings.
Read More
The Pergoveris market is witnessing steady growth over the forecast period, supported by increasing demand for advanced ivf protocols, rising focus on precision hormone therapy.
Read More
The Pergonal market is witnessing steady growth over the forecast period, supported by increasing demand for assisted reproductive technologies, rising investments in fertility care infrastructure.
Read More
The Pentacel market is witnessing steady growth over the forecast period, supported by expansion of universal immunization programs, increasing focus on vaccine coverage in emerging markets.
Read More
The PENBRAYA market is witnessing steady growth over the forecast period, supported by expansion of combination vaccine adoption, increasing government funding for preventive healthcare.
Read More